Skip to main content
Veterinary Medicines

Pimotab 5 mg chewable tablets for dogs

Authorised
  • Pimobendan

Product identification

Medicine name:
Pimotab 5 mg chewable tablets for dogs
Pimotab 5 mg Kautabletten für Hunde
Active substance:
  • Pimobendan
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Pimobendan
    5.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC01CE90
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • Cardboard box of 100 tablets, Aluminium.OPA-Aluminium-PVC blisters containing 10 tablets.
  • Cardboard box of 50 tablets, Aluminium.OPA-Aluminium-PVC blisters containing 10 tablets.
  • Cardboard box of 30 tablets, Aluminium.OPA-Aluminium-PVC blisters containing 10 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • CP-Pharma Handelsgesellschaft mbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402654.00.00
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0297/003
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 15/03/2024
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 20/12/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 20/12/2024

Public Assessment Report Pimotab NL-V-0297-001_005.pdf

English (PDF)
Published on: 15/03/2024
Download